
Lembos Pharmaceuticals LLP
About Lembos Pharmaceuticals LLP
Data last updated:
Lembos Pharmaceuticals LLP is a limited liability partnership (LLP) based in New, Delhi, India. It operates in the pharmaceutical products segment of the pharmaceuticals sector. It was incorporated on 28 November 2015 and has been in existence for over 11 years.
The LLP is registered with the Registrar of Companies (ROC), Delhi, under LLPIN AAF-2347. Its GSTIN is 07AAGFL0705M1ZC (Delhi).
The LLP has a total obligation of contribution of ₹1.53 Lakh. It is led by designated partners including Ajay Prem Juneja and Dewashish Pathak.
Its latest statement of accounts is for the year ended 31 March 2023. The registered office is at H. No. – 508/6 Kh No – 1529 GF Blk – Z Basai Darapur Near Ramesh Nagar Metro Station, New, Delhi, India – 110027.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH. No. – 508/6 Kh No – 1529 GF Blk – Z Basai Darapur Near Ramesh Nagar Metro Station, New, Delhi, India – 110027
- IndustryPharma, Pharmaceutical Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Designated Partners of Lembos Pharmaceuticals LLP
Lembos Pharmaceuticals has 3 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajay Prem Juneja | Designated Partner | 28 Nov 2015 | 10 Years 10 Months | Current |
| Dewashish Pathak | Designated Partner | 28 Nov 2015 | 10 Years 10 Months | Current |
| Dilip Kumar | Designated Partner | 28 Nov 2015 | 10 Years 10 Months | Current |
Financials of Lembos Pharmaceuticals LLP FY 2023 filings available
Financial Statement Summary of Lembos Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Lembos Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Lembos Pharmaceuticals are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of Lembos Pharmaceuticals LLP
Lembos Pharmaceuticals LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Lembos Pharmaceuticals LLP
Employment history and EPFO contributions of people linked to Lembos Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Lembos Pharmaceuticals LLP
Lembos Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAGFL0705M1ZC | Delhi | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Lembos Pharmaceuticals LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Lembos Pharmaceuticals LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Lembos Pharmaceuticals LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Lembos Pharmaceuticals LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Lembos Pharmaceuticals LLP
Frequently Asked Questions about Lembos Pharmaceuticals LLP
Lembos Pharmaceuticals is an active limited liability partnership based in New, Delhi, India. The LLP works in pharmaceutical products, within the pharma industry. It was incorporated on 28 November 2015 (11+ years old) and is registered under LLPIN AAF-2347.
Lembos Pharmaceuticals has 3 current designated partners:
- Ajay Prem Juneja - Designated Partner
- Dewashish Pathak - Designated Partner
- Dilip Kumar - Designated Partner
The GSTIN of Lembos Pharmaceuticals is 07AAGFL0705M1ZC, registered in Delhi.
The LLPIN (Limited Liability Partnership Identification Number) of Lembos Pharmaceuticals is AAF-2347. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Lembos Pharmaceuticals was incorporated on 28 November 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The registered office of Lembos Pharmaceuticals is at H. No. – 5086 Kh No – 1529 GF Blk – Z Basai Darapur Near Ramesh Nagar Metro Station, New, Delhi, India – 110027.
The total obligation of contribution is ₹1.53 Lakh.
Lembos Pharmaceuticals operates in the pharma industry, in the pharmaceutical products segment.
Lembos Pharmaceuticals can be reached at its registered office: H. No. – 5086 Kh No – 1529 GF Blk – Z Basai Darapur Near Ramesh Nagar Metro Station, New, Delhi, India – 110027.